Prevascularization of cardiac patch on the omentum improves its therapeutic outcome.
The recent progress made in the bioengineering of cardiac patches offers a new therapeutic modality for regenerating the myocardium after myocardial infarction (MI). We present here a strategy for the engineering of a cardiac patch with mature vasculature by heterotopic transplantation onto the omentum. The patch was constructed by seeding neonatal cardiac cells with a mixture of prosurvival and angiogenic factors into an alginate scaffold capable of factor binding and sustained release. After 48 h in culture, the patch was vascularized for 7 days on the omentum, then explanted and transplanted onto infarcted rat hearts, 7 days after MI induction. When evaluated 28 days later, the vascularized cardiac patch showed structural and electrical integration into host myocardium. Moreover, the vascularized patch induced thicker scars, prevented further dilatation of the chamber and ventricular dysfunction. Thus, our study provides evidence that grafting prevascularized cardiac patch into infarct can improve cardiac function after MI.
Dvir
Tal
T
Department of Biotechnology Engineering, Ben-Gurion University of the Negev, Beer-Sheva, Israel 84105.
Kedem
Alon
A
Ruvinov
Emil
E
Levy
Oren
O
Freeman
Inbar
I
Landa
Natalie
N
Holbova
Radka
R
Feinberg
Micha S
MS
Dror
Shani
S
Etzion
Yoram
Y
Leor
Jonathan
J
Cohen
Smadar
S
D000818:Animals; D018929:Cell Culture Techniques / Q000379:methods*; D002454:Cell Differentiation; D002478:Cells, Cultured; D004562:Electrocardiography; D006085:Graft Survival; D016027:Heart Transplantation / Q000379:methods*; D008297:Male; D008855:Microscopy, Electron, Scanning; D009203:Myocardial Infarction / Q000503:physiopathology / Q000601:surgery*; D018919:Neovascularization, Physiologic; D009852:Omentum / Q000098:blood supply* / Q000166:cytology / Q000601:surgery*; D051381:Rats; D017207:Rats, Sprague-Dawley; D023822:Tissue Engineering / Q000379:methods*; D016042:Transplantation, Heterotopic; D016896:Treatment Outcome
Circulation. 2000 Nov 7;102(19 Suppl 3):III56-61
11082363
Biomaterials. 2009 Apr;30(11):2122-31
19152972
Circulation. 1997 Jul 1;96(1):116-21
9236425
J Biomed Mater Res. 2002 Jun 15;60(4):668-78
11948526
Am J Physiol Heart Circ Physiol. 2008 Oct;295(4):H1460-9
18660446
FASEB J. 2008 Jun;22(6):1886-93
18285400
Cell Transplant. 2009;18(3):275-82
19558776
Tissue Eng. 2007 Sep;13(9):2185-93
17518740
Eur Surg Res. 1998;30(2):138-43
9565748
Lab Invest. 2001 Apr;81(4):453-63
11304564
Circ Res. 2002 May 31;90(10):1044-54
12039793
Biotechnol Bioeng. 2002 Nov 5;80(3):305-12
12226863
JAMA. 1984 Oct 19;252(15):2034-6
6207314
Cardiovasc Res. 2007 Mar 1;73(4):823-32
17258698
Science. 1997 Feb 14;275(5302):964-7
9020076
Trends Biochem Sci. 2004 Nov;29(11):609-17
15501680
FASEB J. 2007 Oct;21(12):3197-207
17496162
Tissue Eng. 2003 Dec;9(6):1227-32
14670110
Stem Cells. 2008 May;26(5):1376-84
18308946
Circulation. 2002 Dec 10;106(24):3009-17
12473544
Nat Med. 2006 Apr;12(4):452-8
16582915
Tissue Eng. 2005 May-Jun;11(5-6):715-22
15998213
Nat Biotechnol. 2005 Jul;23(7):879-84
15965465
Circulation. 2008 Mar 18;117(11):1388-96
18316487
Nat Biotechnol. 2007 Sep;25(9):1015-24
17721512
J Thorac Cardiovasc Surg. 2004 Jun;127(6):1608-15
15173714
Biomaterials. 2006 Jun;27(17):3249-55
16490250
Annu Rev Physiol. 2006;68:29-49
16460265
Circ Res. 2007 Feb 2;100(2):263-72
17218605
Biomaterials. 2008 Aug;29(22):3260-8
18462788
Circulation. 2005 Aug 30;112(9 Suppl):I173-7
16159811
J Am Coll Cardiol. 2004 Oct 19;44(8):1690-9
15489105
Tissue Eng. 2006 Oct;12(10):2843-52
17518653
Int J Urol. 2006 May;13(5):529-37
16771721